Home » Stocks » Microbot Medical

Microbot Medical Inc. (MBOT)

Stock Price: $6.77 USD -0.13 (-1.88%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 48.09M
Revenue (ttm) n/a
Net Income (ttm) -7.49M
Shares Out 7.10M
EPS (ttm) -1.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $6.77
Previous Close $6.90
Change ($) -0.13
Change (%) -1.88%
Day's Open 6.99
Day's Range 6.59 - 6.99
Day's Volume 180,445
52-Week Range 4.30 - 20.15

More Stats

Market Cap 48.09M
Enterprise Value 19.30M
Earnings Date (est) Aug 18, 2020
Ex-Dividend Date n/a
Shares Outstanding 7.10M
Float 6.80M
EPS (basic) -1.54
EPS (diluted) -1.49
FCF / Share -1.35
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 201,805
Short Ratio 1.58
Short % of Float 3.05%
Beta 5.61
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.70
Revenue n/a
Operating Income -7.49M
Net Income -7.49M
Free Cash Flow -9.67M
Net Cash 28.79M
Net Cash / Share 4.05
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -20.70%
ROE -38.51%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$19.00*
Low
19.0
Current: $6.77
High
19.0
Target: 19.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue-----1.010.170.491.221.43
Revenue Growth-----487.58%-64.82%-59.88%-14.46%-
Gross Profit-----1.010.170.491.011.26
Operating Income-7.24-7.24-5.27-9.64-0.92-30.91-28.09-21.91-28.08-29.36
Net Income-7.25-7.26-7.59-9.66-0.92-32.74-26.44-28.49-21.33-25.24
Shares Outstanding4.272.902.180.950.060.040.030.020.010.01
Earnings Per Share-1.70-2.41-2.76-6.00-0.60-858.60-988.20-1,603.80-2,430.00-3,321.00
Operating Cash Flow-6.45-5.31-4.86-0.79-0.77-27.35-23.32-19.87-22.06-24.52
Capital Expenditures0.04-0.22-0.06-0.03--0.90-4.64-0.07-0.30-0.92
Free Cash Flow-6.41-5.53-4.91-0.81-0.77-28.25-27.96-19.94-22.36-25.44
Cash & Equivalents35.655.2610.812.710.4424.9930.5922.3716.5919.90
Total Debt0.90--0.080.4215.0513.080.350.540.78
Net Cash / Debt34.755.2610.812.630.029.9417.5022.0216.0519.11
Assets37.136.0911.023.370.5332.4341.5630.1725.2130.60
Liabilities5.594.760.561.170.5926.5626.6016.1914.4815.12
Book Value31.541.339.961.70-0.065.8714.9513.9810.7315.48
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Microbot Medical Inc.
Country United States
Employees 10
CEO Harel Gadot

Stock Information

Ticker Symbol MBOT
Stock Exchange NASDAQ
Unique Identifier NASDAQ: MBOT

Description

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.